EP3156056
Lyfjasamsetningar sem innihalda sorbitan-estera
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
19.3.2012EP published:
6.12.2023EP application number:
16185202.5
EP translation filed:
12.2.2024Grant published:
15.3.2024EPO information:
European Patent Register
Max expiry date:
18.3.2032Expiry date:
18.3.2027Next due date:
31.3.2027
Title in English:
PHARMACEUTICAL COMPOSITIONS COMPRISING SORBITAN ESTERSLanguage of the patent:
English
Timeline
Today
19.3.2012EP application
6.12.2023EP Publication
12.2.2024Translation submitted
15.3.2024Registration published
18.3.2027Expires
Owner
Name:
Alkermes Pharma Ireland LimitedAddress:
Connaught House 1 Burlington Road, Dublin 4, IE
Inventor
Name:
HICKEY, Magali, B.Address:
Waltham, MA 02451, US
Name:
PERRY, Jason, M.Address:
Waltham, MA 02451, US
Name:
DEAVER, Daniel, R.Address:
Waltham, MA 02451, US
Name:
REMENAR, Julius, F.Address:
Waltham, MA 02451, US
Name:
VANDIVER, JenniferAddress:
Waltham, MA 02451, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161454008 PDate:
18.3.2011Country:
US
Classification
Categories:
A61K 31/496, A61K 31/551, A61K 9/00, A61P 25/00, A61P 25/18, A61P 25/24
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 6.3.2024
Expires: 18.3.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 13.2.2025
Expires: 18.3.2026
Payer: Árnason Faktor ehf.
Number: 15
Paid: 20.3.2026
Expires: 18.3.2027
Payer: Árnason Faktor ehf.